Market Currents
Nabi Biopharmaceuticals (NABI +1.1%) recovers from its pre-open dip, now trading higher despite...
-
Wednesday, October 17, 2012, 11:00 AM ETNabi Biopharmaceuticals (NABI +1.1%) recovers from its pre-open dip, now trading higher despite its earlier announcement that Phase 2 studies of its smoking-cessation vaccine didn't meet the primary endpoint, creating another setback for the drug.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
